PL Lodz Watala C: Difference between revisions
From Bioblast
Purtschera (talk | contribs) (Created page with "{{MiPNetLab}}") Β |
Purtschera (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
{{MiPNetLab}} | {{MiPNetLab | ||
|address=Watala Cezary | |||
Β | |||
Department of Haemostasis | |||
and Haemostatic Disorders | |||
Β | |||
Medical University of Lodz | |||
Β | |||
113 Zeromskiego Street | |||
Β | |||
90-549 ΕΓ³dΕΊΒ POLAND | |||
|city=Lodz | |||
|country=Poland | |||
|MiPNetLab=Watala C, Labieniec M | |||
|info=[[IOC61]], [http://www.oroboros.at/index.php?id=ioc55-56 IOC55-56] | |||
}} | |||
*Mitochondrial respiratory capacity nder normal and pathophysiological conditions (diabetes mellitu, atherothrombosis, brain-blood barrier disruption, cancerogenesis) | |||
*Pharmacological modulation of mitochondrial function by selected pharmaceuticals of anti-diabetic activity | |||
*targeting of biochemical and molecular burden of diabetes | |||
Revision as of 16:10, 13 May 2011
- Mitochondrial respiratory capacity nder normal and pathophysiological conditions (diabetes mellitu, atherothrombosis, brain-blood barrier disruption, cancerogenesis)
- Pharmacological modulation of mitochondrial function by selected pharmaceuticals of anti-diabetic activity
- targeting of biochemical and molecular burden of diabetes
